Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Digestive System Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT04149691
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies

Who this might be right for
Gastric CancerBladder CancerSquamous Non-small Cell Lung Cancer+4 more
Celon Pharma SA 42
Large-scale testing (Phase 3)Study completedNCT01053390
What this trial is testing

New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma

Who this might be right for
Gallbladder Neoplasms
Shanghai Jiao Tong University School of Medicine 216
Testing effectiveness (Phase 2)Looking for participantsNCT07105748
What this trial is testing

HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA)

Who this might be right for
Mixed Hepatocellular-cholangiocarcinoma
Fudan University 45
Early research (Phase 1)Looking for participantsNCT07503808
What this trial is testing

IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Who this might be right for
Esophageal Squamous Cell CarcinomaHigh Grade Serous Ovarian CancerHead and Neck Squamous Cell Carcinoma+5 more
IDEAYA Biosciences 150
Early research (Phase 1)Study completedNCT03849469
What this trial is testing

XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Who this might be right for
MelanomaCervical CarcinomaPancreatic Carcinoma+20 more
Xencor, Inc. 78
Testing effectiveness (Phase 2)Study completedNCT00717756
What this trial is testing

Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial

Who this might be right for
Liver Cancer
Brown University 41
Testing effectiveness (Phase 2)Ended earlyNCT02423954
What this trial is testing

Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)

Who this might be right for
Advanced CancerPancreatic CancerRenal Cell Cancer+4 more
Western Regional Medical Center 33
Not applicableUnknownNCT04672603
What this trial is testing

Complete Versus Partial Preservation of Denonvilliers' Fascia on Urogenital Function in Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerAdvanced Cancer
Sixth Affiliated Hospital, Sun Yat-sen University 214
Testing effectiveness (Phase 2)UnknownNCT04263870
What this trial is testing

Conversion Therapy With Sintilimab Plus CAPOX in Patients With Unresectable Locally Advanced or Limited Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction

Who this might be right for
Gastroesophageal Junction AdenocarcinomaStomach AdenocarcinomaLocally Advanced Unresectable Gastric Adenocarcinoma+1 more
Sichuan University 36
Early research (Phase 1)Ended earlyNCT05977322
What this trial is testing

A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.

Who this might be right for
Pancreatic Ductal AdenocarcinomaGastroesophageal AdenocarcinomaGlioblastoma Multiforme
Novartis Pharmaceuticals 24
Large-scale testing (Phase 3)UnknownNCT00189683
What this trial is testing

Xeloda Vs Monitoring in Advanced Colorectal Cancer Responsive to Chemotherapy

Who this might be right for
Colorectal Cancer
Association Européenne de Recherche en Oncologie
Testing effectiveness (Phase 2)Ended earlyNCT01271322
What this trial is testing

Sequential FDG-PET (Positron Emission Tomography) and Induction Chemotherapy in Locally Advanced Adenocarcinoma of the Esophagogastric Junction (AEG)

Who this might be right for
Adenocarcinomas of the Esophagogastric Junction
National Center for Tumor Diseases, Heidelberg
Testing effectiveness (Phase 2)Study completedNCT00525005
What this trial is testing

Docetaxel, Oxaliplatin and S-1 (DOS) for Advanced Gastric Cancer

Who this might be right for
Stomach Neoplasms
Hallym University Medical Center 44
Testing effectiveness (Phase 2)Study completedNCT01264705
What this trial is testing

Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
University of Texas Southwestern Medical Center 47
Not applicableStudy completedNCT06195254
What this trial is testing

Stereotactic Body Radiotherapy Combined With PD-1 Blockers for Locally Advanced or Locally Recurrent Pancreatic Cancer

Who this might be right for
Stereotactic Body RadiotherapyPD-1 InhibitorsPancreatic Cancer
Peking University Third Hospital 19
Testing effectiveness (Phase 2)UnknownNCT03575637
What this trial is testing

Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Peking University 180
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03301805
What this trial is testing

A Phase II, EvaluateBLEX 404 Combined With Gemcitabine Monotherapy With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Rgene Corporation 40
Early research (Phase 1)Looking for participantsNCT06043466
What this trial is testing

A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors

Who this might be right for
Colorectal CancerEsophagus CancerGastric Cancer+4 more
Chongqing Precision Biotech Co., Ltd 30
Early research (Phase 1)Looking for participantsNCT06687941
What this trial is testing

Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors

Who this might be right for
NeoplasmsCarcinoma, HepatocellularCarcinoma, Non-Small-Cell Lung+1 more
Aptamer Sciences, Inc. 70
Testing effectiveness (Phase 2)Ended earlyNCT05461794
What this trial is testing

Study To Investigate the Efficacy and Safety of Sitravatinib in Combination With Tislelizumab in Participants With Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
BeiGene 96
Next Page